Pharmaceutical giant Eli Lilly opened its new Concord, NC, facility on Friday. The company has invested more than $2 billion ...
Ashkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection ...
Governor Roy Coope, Eli Lilly officials and others were on hand as the new $2 billion facility opened on Concord Friday, June ...
Wall Street Insights Unlike the declining stocks of some of its pharmaceutical rivals, Eli Lilly has continually beat ...
North Carolina Governor Roy Cooper is in Concord Friday for the ribbon-cutting ceremony of pharmaceutical company Eli Lilly’s ...
INDIANAPOLIS — From the Discovery Park District in West Lafayette to the heart of downtown Indianapolis, America’s Hard-Tech ...
Advancing a strategy several years in the making, Purdue University trustees on Friday (June 7) endorsed the launch of the ...
Eli Lilly has more work it wants to do with the hard-won success from its weight loss and diabetes drugs, Zepbound and Mounjaro, outgoing CFO Anat Ashkenazi told CNBC. The company is working to ...
Eli Lilly's stock has seen significant gains due to the success of its GLP-1 franchise and the potential of donanemab for Alzheimer's disease. The FDA's Advisory Committee endorsed donanemab for ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
An FDA advisory committee voted 11-0 in favor of Eli Lilly and Company's donanemab for the treatment of early Alzheimer's disease. Donanemab has no effect on non-APOE4 carriers, may slow the ...
Eli Lilly and Company (LLY) unveiled a new manufacturing plant in North Carolina on Friday, which, according to the pharmaceutical giant, is expected to alleviate manufacturing bottlenecks for GLP ...